Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Jadon

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Rheumatology|September 3, 2015
Dr. Jadon repliesDeepak Jadon
Best Practice & Research. Clinical Rheumatology|December 25, 2022
Horizon scan: State-of-the-art therapeutics for psoriatic arthritisJoseph Hutton, Philip Mease, Deepak Jadon
Therapeutic Advances in Musculoskeletal Disease|April 15, 2021
A comparison of clinical examination and ultrasound enthesitis indices in patients with psoriatic arthritis, adjusted for concomitant fibromyalgiaMark Sapsford, Jobie Evans, Gavin Clunie, et al.
Clinical Immunology (Orlando, Fla.)|July 27, 2016
Implications of the diversity of class I HLA associations in psoriatic arthritisRobert Winchester, Jon Giles, Deepak Jadon, et al.
Rheumatology (Oxford, England)|October 28, 2017
Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritisCarmel Stober, Weiyu Ye, Thushyanthan Guruparan, et al.
The Journal of Rheumatology|January 17, 2016
Novel Composite Radiographic Score for Longitudinal Observational Studies of Psoriatic Arthritis: A Proof-of-concept StudyWilliam Tillett, Gavin Shaddick, Deepak Jadon, et al.
Annals of the Rheumatic Diseases|January 8, 2013
Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritisWilliam Tillett, Deepak Jadon, Gavin Shaddick, et al.
The Journal of Rheumatology|November 18, 2011
The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity studyWilliam Tillett, Luisa Costa, Deepak Jadon, et al.
Therapeutic Advances in Musculoskeletal Disease|January 17, 2022
Clinical effectiveness of symptomatic therapy compared with standard step-up care for the treatment of low-impact psoriatic oligoarthritis: the two-arm parallel group randomised POISE feasibility studyInes Rombach, Laura Tucker, William Tillett, et al.
Therapeutic Advances in Musculoskeletal Disease|June 3, 2024
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trialMarion Watson, William Tillett, Deepak Jadon, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Rheumatology|September 3, 2015
Dr. Jadon repliesDeepak Jadon
Best Practice & Research. Clinical Rheumatology|December 25, 2022
Horizon scan: State-of-the-art therapeutics for psoriatic arthritisJoseph Hutton, Philip Mease, Deepak Jadon
Therapeutic Advances in Musculoskeletal Disease|April 15, 2021
A comparison of clinical examination and ultrasound enthesitis indices in patients with psoriatic arthritis, adjusted for concomitant fibromyalgiaMark Sapsford, Jobie Evans, Gavin Clunie, et al.
Clinical Immunology (Orlando, Fla.)|July 27, 2016
Implications of the diversity of class I HLA associations in psoriatic arthritisRobert Winchester, Jon Giles, Deepak Jadon, et al.
Rheumatology (Oxford, England)|October 28, 2017
Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritisCarmel Stober, Weiyu Ye, Thushyanthan Guruparan, et al.
The Journal of Rheumatology|January 17, 2016
Novel Composite Radiographic Score for Longitudinal Observational Studies of Psoriatic Arthritis: A Proof-of-concept StudyWilliam Tillett, Gavin Shaddick, Deepak Jadon, et al.
Annals of the Rheumatic Diseases|January 8, 2013
Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritisWilliam Tillett, Deepak Jadon, Gavin Shaddick, et al.
The Journal of Rheumatology|November 18, 2011
The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity studyWilliam Tillett, Luisa Costa, Deepak Jadon, et al.
Therapeutic Advances in Musculoskeletal Disease|January 17, 2022
Clinical effectiveness of symptomatic therapy compared with standard step-up care for the treatment of low-impact psoriatic oligoarthritis: the two-arm parallel group randomised POISE feasibility studyInes Rombach, Laura Tucker, William Tillett, et al.
Therapeutic Advances in Musculoskeletal Disease|June 3, 2024
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trialMarion Watson, William Tillett, Deepak Jadon, et al.
Pageof 3